The Irish Venture Capital Association (IVCA) has elected Dr Manus Rogan, managing partner and founder of Fountain Healthcare Partners, as its new chairman.
He succeeds Maurice Roche, general partner in Delta Partners.
The Irish Venture Capital Association is the representative organisation for venture capital firms in Ireland.
In the last 10 years, Irish VCs have invested €1.5bn into Irish SMEs and have attracted an additional €1.5bn from international VCs through syndication.
Rogan has more than 23 years of investment and operating experience in the life-sciences sector in the US, Europe and Japan. He began his career at GlaxoSmithKline in the UK.
In 1996, he joined Elan Corporation, where he concluded more than 25 investment and technology licensing transactions globally. He currently serves on the board of Opsona Therapeutics and until recently represented Fountain Healthcare Partners on the Amarin Corporation board.
Rogan holds a PhD in chemistry from the University of York (sponsored by GlaxoSmithKline) and an MBA from Trinity College Dublin.